Zu den Inhalten springen

Dr. Andreas Rimner

Leitender Oberarzt | Klinik für Strahlenheilkunde

Curriculum vitae

 

Geburtsort:Frankfurt am Main
Staatsangehörigkeit:deutsch

Beruflicher Werdegang

 

seit 03/2025Wissenschaftlicher Direktor des Tumorzentrums Freiburg – CCCF
seit 08/2024Gründer und Sprecher der AG Thoraxonkologie in der Deutschen Gesellschaft für Radioonkologie (DEGRO)
seit 02/2024Stellvertretender Ärztlicher Direktor und Leitender Oberarzt, Klinik für Strahlenheilkunde, Universität Freiburg, Deutschland
07/2019 – 01/2024Direktor für Thoraxforschung, Abteilung der Radioonkologie am Memorial Sloan Kettering Cancer Center, New York, USA
11/2018 – 01/2024Associate Attending und Professor, Abteilung der Radioonkologie am Memorial Sloan Kettering Cancer Center, New York, USA
04/2015 – 11/2018 Assistant Attending und Professor, Abteilung der Radioonkologie am Memorial Sloan Kettering Cancer Center, New York, USA
08/2010 – 06/2019Leitung der Sektion für thorakale Tumoren, Abteilung der Radioonkologie am Memorial Sloan Kettering Cancer Center, New York, USA
08/2010 – 03/2015 Assistant Attending, Level 1, Abteilung der Radioonkologie am Memorial Sloan Kettering Cancer Center, New York, USA
05/2011Radioonkologie-Facharztanerkennung vom American Board of Radiology
08/2010 – 01/2024Leitung und Expansion der Sektion für thorakale Tumoren, Abteilung der Radioonkologie am Memorial Sloan Kettering Cancer Center, New York, USA
04/2009 – 03/2012Assistenzarztsprecher/Chief Resident,  Abteilung der Radioonkologie am Memorial Sloan Kettering Cancer Center, New York, USA
07/2006 – 06/2010Assistenzarztausbildung/Residency zum Facharzt der Radioonkologie am Memorial Sloan Kettering Cancer Center, New York, USA
08/2003 – 06/2005Postdoctoral Research Fellow im Laboratory of Radiation Biology (Arbeitsgruppe Prof. Zvi Fuks), Memorial Sloan Kettering Cancer Center, New York, USA
10/2004Medizinische Approbation
 Promotionsarbeit zum Thema „Identifizierung radio-induzierbarer Gene in humanen malignen Gliomzellen„ (summa cum laude) an der Neurologischen Universitätsklinik Tübingen, (Arbeitsgruppe Prof. Michael Weller) 
1995-2003Studium der Humanmedizin an der Eberhard-Karls-Universität Tübingen

 

Stipendien/Auszeichnungen


Kongresspräsident des Jahreskongresses der International Thymic Malignancies Interest Group (ITMIG) 2023

Vice Chair und Chair-Elect des American Radium Society Appropriate Use Criteria Thoracic Committee 2022 - jetzt

Mitglied des Research Council, Memorial Sloan Kettering Cancer Center, New York 2021 - 2024

Castle Connolly Top Doctor New York 2021 - 2024

Board member der International Mesothelioma Interest Group 2018 - jetzt

ASTRO Annual Meeting Scientific Committee Lung Track Chair 2018 - 2021

Mitglied des American Board of Radiology Prüfungskommittees für Thoracic Cancers and Sarcomas 2018- jetzt

Vice President der International Thymic Malignancies Interest Group (ITMIG) 2017 - 2023

Mitglied des IASLC Staging and Prognostic Factors Committee (SPFC) 2017 - jetzt

Distinguished Teaching Award in Clinical Radiation Oncology, MSKCC, New York, NY 2016

Mitglied des Institutional Review Board/Privacy Board, Memorial Sloan Kettering Cancer Center, New York 2015 - 2019

ASTRO Annual Meeting Scientific Committee Lung Track Vice-Chair 2015 - 2018

Mitglied des NRG Oncology Lung Cancer Core Committee 2014 - 2024

ITMIG Barbara Neibauer Award for the Best Paper on Thymic Carcinomas 2014

IMIG 2012 New Young Investigator Award for the best clinical abstract 2012

ARRO Best of ASTRO Abstract at the Annual Meeting 2010

Mortimer J. Lacher lymphoma fellowship 2009 - 2010

Stipendium der International Rotary Foundation für akademische Studien im Rahmen des Praktischen Jahres im  Brain Tumor Center und Chirurgie, Massachusetts General Hospital, Harvard Medical School, Boston, USA (Mentoren: Prof. Fred H. Hochberg und Prof. Kenneth K. Tanabe) 2002 - 2003

Stipendium des Deutschen Akademischen Austauschdienstes (DAAD) und Biomedical Sciences Exchange Program (BMEP) für akademische Studien im  Laboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, im Rahmen des BMEP-Austauschprogrammes (Arbeitsgruppe Prof. Richard N. Kolesnick) 2000 - 2001

Ehrenurkunde des Ministeriums für Kultus und Sport Baden- Württemberg und Stipendium der Kunststiftung Baden-Württemberg zum 1. Preis beim Bundeswettbewerb „Jugend musiziert“ 1995


Ausgewählte Publikationen

 

Meng YJ, Mankuzhy NP, Chawla M, Lee RP, Yorke ED, Zhang Z, Gelb E, Lim SB, Cuaron JJ, Wu AJ, Simone CB 2nd, Gelblum DY, Lovelock DM, Harris W, Rimner A. A Prospective Study on Deep Inspiration Breath Hold Thoracic Radiation Therapy Guided by Bronchoscopically Implanted Electromagnetic Transponders. Cancers (Basel). 2024 Apr 17;16(8):1534. doi: 10.3390/cancers16081534. PMID: 38672616; PMCID: PMC11048337.

Rimner A, Gelblum DY, Wu AJ, Shepherd AF, Mueller B, Zhang S, Cuaron J, Shaverdian N, Flynn J, Fiasconaro M, Zhang Z, von Reibnitz D, Li H, McKnight D, McCune M, Gelb E, Gomez DR, Simone CB 2nd, Deasy JO, Yorke ED, Ng KK, Chaft JE. Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small
Cell Lung Cancer: A Phase 1 Dose-Escalation Trial. Int J Radiat Oncol Biol Phys. 2024 Jul 1;119(3):869-877. doi: 10.1016/j.ijrobp.2023.12.018. Epub 2023 Dec 26. PMID: 38154510.

Rimner A, Ahmad U, Lobaugh SM, Zhang Z, Shepherd AF, Huang J, Antonicelli A, Girard N, Moser B, Filosso P, Lucchi M, Marom EM, Roden A, Detterbeck F, Ruffini E, Simone CB 2nd. Postoperative Radiation Therapy for Thymic Carcinoma: An Analysis of the International Thymic Malignancy Interest Group/European Society of Thoracic Surgeons Database. J Thorac Oncol. 2024 Apr;19(4):626-635. doi: 10.1016/j.jtho.2023.12.011. Epub 2023 Dec 8. PMID: 38070599.

Thor M, Fitzgerald K, Apte A, Oh JH, Iyer A, Odiase O, Nadeem S, Yorke ED, Chaft J, Wu AJ, Offin M, Simone Ii CB, Preeshagul I, Gelblum DY, Gomez D, Deasy JO, Rimner A. Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation. Radiother Oncol. 2024 Jan;190:109983. doi: 10.1016/j.radonc.2023.109983. Epub 2023

Rimner A, Ruffini E, Cilento V, Goren E, Ahmad U, Appel S, Bille A, Boubia S, Brambilla C, Cangir AK, Detterbeck F, Falkson C, Fang W, Filosso PL, Giaccone G, Girard N, Guerrera F, Huang J, Infante M, Kim DK, Lucchi M, Marino M, Marom EM, Nicholson AG, Okumura M, Rami-Porta R, Simone CB 2nd, Asamura H; Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards, and Participating Institutions. The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: An Overview of the Central Database Informing Revision of the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol. 2023 Oct;18(10):1386-1398. doi: 10.1016/j.jtho.2023.07.008. Epub 2023 Sep 11. PMID: 37702630.

Chun SG, Rimner A, Amini A, Chang JY, Donington J, Edelman MJ, Geng Y, Gubens MA, Higgins KA, Iyengar P, Movsas B, Ning MS, Park HS, Rodrigues G, Wolf A, Simone CB 2nd. American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma. JAMA Oncol. 2023 Jul 1;9(7):971-980. doi: 10.1001/jamaoncol.2023.1175. PMID: 37186595; PMCID: PMC11665036.

Rimner A, Moore ZR, Lobaugh S, Geyer A, Gelblum DY, Abdulnour RE, Shepherd AF, Shaverdian N, Wu AJ, Cuaron J, Chaft JE, Zauderer MG, Eng J, Riely GJ, Rudin CM, Els NV, Chawla M, McCune M, Li H, Jones DR, Sopka DM, Simone CB 2nd, Mak R, Weinhouse GL, Liao Z, Gomez DR, Zhang Z, Paik PK. Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis. Int J Radiat Oncol Biol Phys. 2023 Aug 1;116(5):1091-1099. doi: 10.1016/j.ijrobp.2023.02.030. Epub 2023 Mar 7. PMID: 36889516; PMCID: PMC10751877.

Rimner A, Adusumilli PS, Offin MD, Solomon SB, Ziv E, Hayes SA, Ginsberg MS, Sauter JL, Gelblum DY, Shepherd AF, Guttmann DM, Eichholz JE, Zhang Z, Ritter E, Wong P, Iqbal AN, Daly RM, Namakydoust A, Li H, McCune M, Gelb EH, Taunk NK, von Reibnitz D, Tyagi N, Yorke ED, Rusch VW, Zauderer MG. A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma. JTO Clin Res Rep. 2022 Dec 1;4(1):100440. doi: 10.1016/j.jtocrr.2022.100440. PMID: 36590015; PMCID: PMC9801123.

Jee J, Lebow ES, Yeh R, Das JP, Namakydoust A, Paik PK, Chaft JE, Jayakumaran G, Rose Brannon A, Benayed R, Zehir A, Donoghue M, Schultz N, Chakravarty D, Kundra R, Madupuri R, Murciano-Goroff YR, Tu HY, Xu CR, Martinez A, Wilhelm C, Galle J, Daly B, Yu HA, Offin M, Hellmann MD, Lito P, Arbour KC, Zauderer MG, Kris MG, Ng KK, Eng J, Preeshagul I, Victoria Lai W, Fiore JJ, Iqbal A, Molena D, Rocco G, Park BJ, Lim LP, Li M, Tong-Li C, De Silva M, Chan DL, Diakos CI, Itchins M, Clarke S, Pavlakis N, Lee A, Rekhtman N, Chang J, Travis WD, Riely GJ, Solit DB, Gonen M, Rusch VW, Rimner A, Gomez D, Drilon A, Scher HI, Shah SP, Berger MF, Arcila ME, Ladanyi M, Levine RL, Shen R, Razavi P, Reis-Filho JS, Jones DR, Rudin CM, Isbell JM, Li BT. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer. Nat Med. 2022 Nov;28(11):2353-2363. doi: 10.1038/s41591-022-02047-z. Epub 2022 Nov 10. PMID: 36357680; PMCID: PMC10338177.

Spigel DR, Faivre-Finn C, Gray JE, Vicente D, Planchard D, Paz-Ares L, Vansteenkiste JF, Garassino MC, Hui R, Quantin X, Rimner A, Wu YL, Özgüroğlu M, Lee KH, Kato T, de Wit M, Kurata T, Reck M, Cho BC, Senan S, Naidoo J, Mann H, Newton M, Thiyagarajah P, Antonia SJ. Five-year survival outcomes from the PACIFIC trial: Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer. J Clin Oncol. 2022 Apr 20;40(12):1301-1311. doi:10.1200/JCO.21.01308. Epub 2022 Feb 2.

Tsao AS, Pass HI, Rimner A, Mansfield AS. New era of malignant pleural mesothelioma: Updates on therapeutic options. J Clin Oncol. 2022 Feb 20;40(6):681-692. doi: 10.1200/JCO.21.01567. Epub 2022 Jan 5. PMID: 34985934; PMCID: PMC8853621.

Chaft J*, Rimner A*, Weder W, Azzoli C, Kris M, Cascone M. Evolution of systemic therapy for patients with stages I-III non-metastatic non-small cell lung cancer. Nature Reviews Clinical Oncology 2021 Sep;18(9):547-557. doi: 10.1038/s41571-021-00501-4. *These authors contributed equally

Wang C, Rimner A, Gelblum DY, Flynn J, Jackson A, Yorke E, Wu AJ. Analysis of Toxic Effects With Antiangiogenic Agents Plus Stereotactic Body Radiation in Ultracentral Lung Tumors. JAMA Oncol. 2019 May 1;5(5):737-739.

Wu AJ, Gillis A, Foster A, Woo K, Zhang Z, Gelblum DY, Downey RJ, Rosenzweig KE, Ong L, Perez CA, Pietanza MC, Krug L, Rudin CM, Rimner A. Patterns of failure in limited-stage small cell lung cancer: Implications of TNM stage for prophylactic cranial irradiation. Radiother Oncol 2017; 125(1):130-135.

Rimner A, Lovie S, Hsu M, Chelius M, Zhang Z, Chau K, Moskowitz AJ, Matasar M, Moskowitz CH, Yahalom J. Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients with Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience. Int J Radiat Oncol Biol Phys 2017; 97(5): 1066-1076.

Rimner A, Yao X, Huang J, Antonicelli A, Ahmad U, Korst RJ, Detterbeck F, Gomez DR. Postoperative Radiation Therapy is Associated with Longer Overall Survival in  Completely Resected Stage II and III Thymoma – An Analysis of the International Thymic Malignancies Interest Group (ITMIG) Retrospective Database. J Thorac Oncol 2016; 11(10): 1785-1792.

Rimner A*, Zauderer MG*, Gomez DR, Adusumilli P, Parhar P, Wu AJ, Woo KM, Shen R, Ginsberg M, Yorke ED, Rice DC, Tsao AS, Rosenzweig KE, Rusch VW, Krug LM. A Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) as Part of Lung-Sparing Multimodality Therapy in Patients with Malignant Pleural Mesothelioma. J Clin Oncol 2016; 34(23):2761-2768.

Din SU, Williams EL, Jackson A, Rosenzweig KE, Wu AJ, Foster A, Yorke ED, Rimner A. Impact of Fractionation and Dose in a Multivariate Model for Radiation-Induced Chest Wall Pain. Int J Radiat Oncol Biol Phys 2015; 93(2):418-424.

Cuaron JJ, Yorke E, McLane A, Liu F, Jackson A, Mychalczak M, Wu A, Rosenzweig KE, Rimner A. Stereotactic Body Radiation Therapy for Primary Lung Cancers ≥3cm. J Thoracic Oncology 2013; 8(11):1396-1401

Rimner A, Brennan MF, Zhang Z, Singer S, Alektiar KM. Influence of compartmental involvement on the patterns of morbidity in soft tissue sarcoma of the thigh. Cancer 2009; 115:149-157.